The major players in the Active Pharmaceutical Ingredients (API) market are, Teva, Mylan, DSM, Aurobindo Pharma, Aspen, Novartis, BASF, Pfizer, Huahai Pharmaceutical, Hisun Pharmaceutical, Sun Pharmaceutical Industries, Zhejiang Medicine, Dr. Reddys Laboratories, Zhejiang NHU, Bayer, NCPC, AbbVie, Shandong Xinhua Pharmaceutical, Northeast Pharm, Harbin Pharmaceutical, LKPC.

Press Release

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from XX USD/MT to XX USD/MT. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Active Pharmaceutical Ingredients includes synthetic APIs, biotech APIs, and the proportion of synthetic APIs is about 85%, and the proportion is in decreasing trend. Active Pharmaceutical Ingredients is widely used in CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology, and other fields. The most proportion of Active Pharmaceutical Ingredients is used for cardiovascular, and the proportion is XX%.

Global Active Pharmaceutical Ingredients (API) Market Professional Survey Report 2018 is a professional and in-depth study and available exclusively through Trusted Business Insights. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets in this 123 pages report.

This market report provides in-depth analytics of the Active Pharmaceutical Ingredients (API) industry including definition, classification, application and industry chain structure. The report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share, and contact information.

Request for a Sample PDF of Active Pharmaceutical Ingredients (API) research report

Active Pharmaceutical Ingredients (API) market report includes an in-depth analysis of the competitive landscape of this business vertical, constituting companies like:

Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddys Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC

Products Segmentation, this report displays the production, revenue, price, market share, and growth rate of each type as below:

Synthetic APIs
Biotech APIs

By Industrial Application, the market can be split into:

CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

Market Segment by Regions includes:

  • North America (the USA, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, and Italy)
  • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
  • South America
  • Middle East and Africa.

Browse contents of Global Active Pharmaceutical Ingredients (API) Market Professional Survey Report 2018

Contacts

Trusted Business Insights
Jessica Wang
Media & Marketing Executive
[email protected]
US: +1 646 568 9797
UK: +44 330 808 0580